ADVB - Wutah bathi EPS kuartalan Advanced Biomed

Advanced Biomed Inc (ADVB) is recruiting technical specialists to develop early tumor detection systems. Diversified supply channels ensure the stability of diagnostic microchip deliveries. A scientific approach and bonus programs help retain leading biologists. Analyzing the chart on GURU.Markets, we find that the quarterly EPS trend resulted in a figure that settled at -1139.40.

By expanding rapid cancer screening through laboratory partnerships and microfluidic chips, Advanced Biomed Inc (ADVB) directly impacts its market capitalization through operational efficiency. By analyzing the quarterly change in EPS, an investor assesses the net profit per share trend, which allows for the mathematical confirmation of the business's financial stability and the determination of the asset's real liquidity buffer, excluding subjective market expectations.